MedCline™ Found to Significantly Reduce Recumbent Esophageal Acid Exposure in Study Published by Journal of Clinical Gastroenterology

The Journal of Clinical Gastroenterology (July 2015) has published the results of a study in which the MedCline sleep positioning system was found to maintain an effective inclined, left-lateral position to significantly reduce recumbent esophageal acid exposure for the treatment of GERD.

The Journal of Clinical Gastroenterology (July 2015) has published the results of a new sleep positioning study, which utilized MedCline™ to create and maintain an ideal sleep position for the treatment of GERD. The use of MedCline was shown to reduce esophageal acid exposure by 87% and reflux episodes by 38%, as compared to a traditional bed wedge. The study results confirm MedCline™ as an effective treatment for those who suffer with nighttime symptoms, such as heartburn and regurgitation.

The article is available on the Journal of Clinical Gastroenterology at: journals.lww.com/jcge/Abstract/publishahead/A_Novel_Sleep_Positioning_Device_Reduces.98453.aspx or via Pubmed at: www.ncbi.nlm.nih.gov/pubmed/26053170.

Though there have been many studies to assess the effects of an inclined position or a left-lateral position on the frequency and duration of acid reflux episodes, A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trial is the first-ever study to evaluate the compounding benefits of combining these two positions.

In addition to this study, there are multiple studies currently underway which are utilizing MedCline to create and maintain an inclined, left-lateral position to effectively treat nocturnal GERD for different patient populations and clinical applications. For more information MedCline clinical trial result, contact Aaron Clark at 858-605-1747.